Cargando…
High Affinity Dopamine D(3) Receptor (D(3)R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D(3)R Knockout Mice
[Image: see text] The dopamine D(3) receptor (D(3)R) is a promising target for the development of pharmacotherapeutics to treat substance use disorders. Several D(3)R-selective antagonists are effective in animal models of drug abuse, especially in models of relapse. Nevertheless, poor bioavailabili...
Autores principales: | Boateng, Comfort A., Bakare, Oluyomi M., Zhan, Jia, Banala, Ashwini K., Burzynski, Caitlin, Pommier, Elie, Keck, Thomas M., Donthamsetti, Prashant, Javitch, Jonathan A., Rais, Rana, Slusher, Barbara S., Xi, Zheng-Xiong, Newman, Amy Hauck |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2015
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937837/ https://www.ncbi.nlm.nih.gov/pubmed/26203768 http://dx.doi.org/10.1021/acs.jmedchem.5b00776 |
Ejemplares similares
-
Novel Analogues
of (R)-5-(Methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (Sumanirole) Provide Clues to Dopamine D(2)/D(3) Receptor Agonist Selectivity
por: Zou, Mu-Fa, et al.
Publicado: (2016) -
A highly D(3)R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D(3)R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use disorder
por: Galaj, Ewa, et al.
Publicado: (2022) -
Dopamine Receptor D(1)R and D(3)R and GRK4
Interaction in Hypertension
por: Zeng, Chunyu, et al.
Publicado: (2023) -
Asthme et usage d’héroïne
por: Underner, Michel, et al.
Publicado: (2017) -
Dopamine D(1) and D(3) Receptors Modulate Heroin-Induced Cognitive Impairment through Opponent Actions in Mice
por: Zhu, Yongsheng, et al.
Publicado: (2016)